Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.84 EUR | 0.00% | +5.14% | 0.00% |
2023 | Pangaea Oncology, S.A. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
2023 | Pangaea Oncology, S.A. Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
0.00% | 58.89M | |
+29.77% | 49.46B | |
+1.00% | 42.58B | |
+49.56% | 42.49B | |
-5.26% | 29.09B | |
+13.68% | 26.61B | |
-22.99% | 18.64B | |
+8.22% | 13.16B | |
+32.41% | 12.55B | |
+24.01% | 12.1B |
- Stock Market
- Equities
- PANG Stock
- News Pangaea Oncology, S.A.
- Pangaea Oncology, S.A. announced that it expects to receive €3.875 million in funding